Is Aveanna Healthcare Holdings (AVAH) Cheap On Value Metrics And Earnings Outlook?

Aveanna Healthcare Holdings Inc

Aveanna Healthcare Holdings Inc

AVAH

0.00

Fresh attention on Aveanna Healthcare Holdings (AVAH) has been triggered by recent coverage highlighting its value profile, as P/E, P/S, and P/CF ratios point to a potentially undervalued stock with a positive earnings outlook.

The recent focus on Aveanna Healthcare Holdings comes after a sharp 31.73% 1 month share price return and a 90 day share price gain of 38.99%, while the 1 year total shareholder return is 131.19% and the 3 year total shareholder return is a little over 4.5x. This points to strong long term momentum despite some short term pullbacks.

If the value case for Aveanna Healthcare Holdings has caught your eye, this can be a good moment to broaden your search into other potential opportunities with our 40 healthcare AI stocks

After a move like this, the real tension for Aveanna Healthcare Holdings is whether the valuation still offers more upside for new buyers or is now better suited to investors who are already in and thinking about risk management.

Most Popular Narrative: 6.1% Undervalued

The most followed narrative on Aveanna Healthcare Holdings compares a fair value of $9.95 to the last close of $9.34, framing the recent rally against a modest valuation gap.

Accelerating adoption of home-based healthcare and increasing patient preference for in-home care are driving strong and sustained demand for Aveanna's services, which management repeatedly noted remains robust and outstrips the company's current capacity, supporting the potential for significant future revenue growth as the company hires and retains more caregivers.

Want to see what sits behind that demand story? The narrative leans on measured revenue growth, thinner margins, and a richer future earnings multiple. The tension between slower earnings and a higher valuation anchor is where things get interesting.

According to this widely followed view, Aveanna Healthcare Holdings reaches that $9.95 fair value using a discount rate of 7.88%, moderate top line growth assumptions, and a lower profit margin profile than today. It also builds in a higher share count over time and a future P/E multiple that is above the current level but closer to sector norms, which together help explain why the stock screens as undervalued despite analysts expecting earnings to be lower several years from now.

Result: Fair Value of $9.95 (UNDERVALUED)

However, Aveanna Healthcare Holdings still faces pressure from caregiver wage inflation and heavy exposure to Medicaid and Medicare reimbursement, both of which could squeeze margins and challenge that undervalued thesis.

Next Steps

Seeing both optimism and concern around Aveanna Healthcare Holdings in this article, it makes sense to review the numbers yourself and then decide on your own stance with the help of 3 key rewards and 3 important warning signs

Looking for more investment ideas beyond Aveanna Healthcare Holdings?

While Aveanna Healthcare Holdings may be on your radar, widening your watchlist now can help you spot other opportunities before they move out of reach.

  • Target reliable income by scanning for companies with strong payouts and resilient cash flows using the 8 dividend fortresses.
  • Hunt for quality at a sensible price by checking stocks that combine appealing valuations with solid fundamentals through the 44 high quality undervalued stocks.
  • Get ahead of the crowd by reviewing financially sound companies flying under most investors' radars via the screener containing 20 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.